Not Yet Recruiting Tocilizumab in Chronic Inflammatory CPPD Disease NCT07254637 Conditions Arthritis, Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis, +3 more Locations Groupe Hospitalier de l'Institut Catholique de Lille — Lomme, Lille, France Lariboisière hospital — Paris, Paris Paris, France Centre Hospitalier Sud-Francilien — Corbeil-Essonnes, Paris, France CHU de Dijon — Dijon, France View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Calcium Pyrophosphate Deposition (CPPD) Disease NCT07005804 Conditions Arthritis, Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis, +6 more Locations Hôpital Saint-Philibert (GHICL) — Lomme, France View Trial Details
Not Yet Recruiting Baricitinib in CPPD - the BAPTIST Study NCT06768294 Conditions Arthritis, Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis, +3 more Locations IRCCS Galeazzi - Sant Ambrogio Hospital — Milan, Italy View Trial Details
Completed Effect of Probenecid on Synovial Fluid ATP Levels in CPPD NCT02243631 Conditions Arthritis, Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis, +3 more Locations Clement J. Zablocki VA Medical Center, Milwaukee, WI — Milwaukee, Wisconsin, United States View Trial Details
